US FTC's in-house antitrust case against PBMs stayed for two weeks
MLex Summary: The US Federal Trade Commission's in-house enforcement action against pharmacy benefit managers Caremark Rx, Express Scripts, OptumRx and their affiliated group purchasing organizations over allegedly inflated insulin prices has...To view the full article, register now.
Already a subscriber? Click here to view full article